Company: PETVW
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023398
Chunk: 67

Company: PetVivo Holdings, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 2
Chunk 67
---
19,395,401 for the six months ended September 30, 2025 and 2024,
respectively.

LIQUIDITY
AND CAPITAL RESOURCES

As
of September 30, 2025, our current assets were $2,109,723, including $767,914 in cash and cash equivalents. In comparison, our current
liabilities as of that date were $1,052,694 including $988,979 of accounts payable and accrued expenses. Our working capital as of September
30, 2025 was $1,057,029.

The
Company has continued to realize losses from operations. As a result of our private placement offering with proceeds of $5,000,000 from
the sale of Series B convertible preferred stock, we do not believe we will have sufficient cash to meet our anticipated operating costs
and capital expenditure requirements for at least the next twelve months. We will need to raise additional capital in the future to support
our efforts to commercialize Spryng® and our ongoing operations. We expect to continue to raise additional capital through the sale
of our securities from time to time for the foreseeable future to fund our business expansion. Our ability to obtain such additional
capital will likely be subject to various factors, including our overall business performance and market conditions. There can be no
guarantee that the Company will be successful in its ability to raise additional capital to fund its business plan.

Net
Cash Used in Operating Activities – We used $3,828,209 of net cash in operating activities for the six months ended September
30, 2025. This cash used in operating activities was primarily attributable to our net loss of $5,318,846 and a decrease of accounts
payable and accrued expenses of $786,183, along with the increased PrecisePRP™ production and inventory ramp-up.

Net
Cash Used in Investing Activities – During the six months ended September 30, 2025, net cash used in investing activities
was $6,605. This cash used in investing activities was primarily attributable to the purchase of equipment.

Net
Cash Provided by Financing Activities – During the six months ended September 30, 2025, net cash provided by financing
activities of $4,361,829 consisted of proceeds of Series B preferred stock receivable of $4,400,000, proceeds from the issuance of convertible
debentures of $160,000 and proceeds from the exercise of a warrant of $140,000.